Impact of trisomy 21 on human trophoblast behaviour and hormonal function

Placenta

Volumn 25, Issue SUPPL. A, 2004, Pages

  Pidoux, G ^a   Guibourdenche, J ^a,b   Frendo, J L ^a   Gerbaud, P ^a   Conti, M ^c   Luton, D ^b   Muller, F ^a,b   Evain Brion, D ^a  

^a INSERM   (France)

^b HÔPITAL ROBERT DEBRÉ   (France)

^c BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; CATALASE; CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE PEROXIDASE; HUMAN PLACENTA LACTOGEN; LEPTIN; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ANEUPLOIDY; ARTICLE; CELL AGGREGATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL FUSION; CELL STRUCTURE; CONTROLLED STUDY; CYTOTROPHOBLAST; ENZYME ACTIVITY; FEMALE; FETOPLACENTAL UNIT; GENE ACTIVITY; GENE DOSAGE; GENE EXPRESSION; GENETIC DISORDER; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PLACENTA DEVELOPMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYNCYTIOTROPHOBLAST; TRISOMY 21; TROPHOBLAST;

EID: 1942454859     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2004.01.007     Document Type: Article

References (46)

1. Pandya P, Snijders R, Johnson S, Brizot M, Nicolaides K. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation. Br J Obstet Gynaecol 1995;102: 957-62.
2. Bogart M, Pandian M, Jones O. Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities. Prenat Diagn 1987;7:623-30.
3. Merkatz I, Nitowsky H, Macri J, Johnson W. An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities. Am J Obstet Gynecol 1984;148:886-94.
4. Wald N, Watt H, Hackshaw A. Integrated screening for Down's syndrome on the basis of tests performed during the first and second trimesters. N Engl J Med 1999;341:461-7.
5. Alsat E, Guibourdenche J, Luton D, Frankenne F, Evain-Brion D. Human placental growth hormone. Am J Obstet Gynecol 1997; 177:1526-34.
6. Handwerger S. The physiology of placental lactogen in human pregnancy. Endocrinology 1991;12:329-36.
7. Jameson J, Hollenberg A. Regulation of chorionic gonadotropin gene expression. Endocr Rev 1993;14:203-21.
8. Kliman H, Nestler J, Sermasi E, Sanger J, Strauss III J. Purification, characterization, and in vitro differenciation of cytotrophoblasts from human term placentae. Endocrinology 1986;118:1567-82.
9. Alsat E, Mirlesse V, Fondacci C, Dodeur M, Evain-Brion D. Parathyroid hormone increases epidermal growth factor receptors in cultured human trophoblastic cells from early and term placenta. J Clin Endocrinol Metab 1991;73:288-94.
10. Kaufmann P, Scheffen I. In: Neonatal and fetal medicine: physiology and pathophysiology. Orlando.
11. Eldar-Geva T, Hochberg A, deGroot N, Weinstein D. High maternal serum chorionic gonadotropin level in Downs' syndrome pregnancies is caused by elevation of both subunits messenger ribonucleic acid level in trophoblasts. J Clin Endocrinol Metab 1995;80:3528-31.
12. Frendo J-L, Vidaud M, Guibourdenche J, Luton D, Muller F, Bellet D et al. Defect of villous cytotrophoblast differentiation into syncytiotrophoblast in Down syndrome. J Clin Endocrinol Metab 2000;85:3700-7.
13. Massin N, Frendo J-L, Guibourdenche J, Luton D, Giovangrandi Y, Muller F et al. Defect of syncytiotrophoblast formation and hCG expression in Down's syndrome. Placenta 2001;22(Suppl A):S93-7.
14. Benirschke K, Kaufmann P. Pathology of the human placenta. New York, 2000, p. 22-70.
15. Oberweiss D, Gillerot Y, Koulischer L, Hustin J, Philippe E. Le placenta des Trisomie 21 dans le dernier trimestre de la gestation. J Gynecol Obstet Biol Reprod 1983;12:345-9.
16. Roberts L, Sebire N, Fowler D, Nicolaides K. Histomorphological features of chorionic vill at 10-14 weeks of gestation in trisomic and chromosomally normal pregnancies. Placenta 2000;21:678-83.
17. Frendo J-L, Thérond P, Bird T, Massin N, Muller F, Guibourdenche J et al. Overexpression of copper zinc superoxide dismutase impairs human trophoblast cell fusion and differentiation. Endocrinology 2001;142: 3638-48.
18. Frendo J-L, Therond P, Guibourdenche J, Vidaud M, Evain-Brion D. Implication of copper zinc superoxide dismutase (SOD-1) in human placenta development. Ann N Y Acad Sci 2002;973:297-301.
19. Thérond P, Gerbaud P, Dimon S, Anderson W, Evain-Brion D, Raynaud F. Antioxidant enzymes in psoriatic fibroblasts and erythrocytes. J Invest Dermatol 1996;106:1325-8.
20. Frendo J-L, Guibourdenche J, Pidoux G, Vidaud M, Luton D, Giovangrandi Y et al. Trophoblast production of a weakly bioactive human chorionic gonadotropin in trisomy 21-affected pregnancy. J Clin Endocrinol Metab 2003b in press.
21. Guibourdenche J, Tarrade A, Laurendeau I, Rochette-Egly C, Chambon P, Vidaud M et al. Retinoids stimulate leptin synthesis and secretion in human syncytiotrophoblast. J Clin Endocrinol Metab 2000;85:2550-5.
22. Masuzaki H, Ogawa Y, Sagawa N, Hosoda K, Matsumoto T, Mise H et al. Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans. Nat Med 1997;3:1029-33.
23. Blond J-L, Lavillette D, Cheynet V, Bouton O, Oriol G, Chapel-Fernandes S et al. An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor. J Virol 2000;74:3321-9.
24. Mi S, Lee X, Li X-P, Veldman GM, Finnerty H, Racie L et al. Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis. Nature 2000;403:785-9.
25. Frendo J-L, Olivier D, Cheynet V, Blond J-L, Vidaud M, Rabreau M et al. Direct involvement of HERV-W Env glycoprotein in human trophoblast cell fusion and differentiation. Mol Cell Biol 2003c; 23:3566-74.
26. Cronier L, Frendo J-L, Defamie N, Pidoux G, Bertin G, Guibourdenche J et al. Requirement of gap junctional intercellular communication for human villous trophoblast differentiation. Biol Reprod 2003 in press.
27. Frendo J-L, Cronier L, Bertin G, Guibourdenche J, Vidaud M, Evain-Brion D et al. Involvement of connexin 43 in human trophoblast cell fusion and differentiation. J Cell Sci 2003a;116:3413-21.
28. Getsios S, MacCalman C. Cadherin-11 modulates the terminal differentiation and fusion of human trophoblastic cells in vitro. Dev Biol 2003; 257:41-54.
29. Alsat E, Wyplosz P, Malassiné A, Guibourdenche J, Porquet D, Nessmann C et al. Hypoxia impairs cell fusion and differentiation process in human cytotrophoblast, in vitro. J Cell Physiol 1996;168:346-53.
30. Esterman A, Greco M, Mitani Y, Finlay T, Ismail-Beigi F, Dancis L. The effect of hypoxia on human trophoblast in culture: morphology, glucose transport and metabolism. Placenta 1997;18:129-36.
31. Nelson D, Johnson R, Smith S, Anteby E, Sadovsky Y. Hypoxia limits differentiation and up-regulates expression and activity of prostaglandin H synthase 2 in cultured trophoblast from term human placenta. Am J Obstet Gynecol 1999;180:896-902.
32. Jones C, Fox C. An ultrastructural and ultrahistochemical study of the placenta in maternal essential hypertension. Placenta 1981;2:193-204.
33. Van Der Veen F, Fox C. The human placenta in idiopathic intrauterine growth retardation: a light and electron microscopic study. Placenta 1983; 4:65-73.
34. Finkel T. Oxygen radicals and signaling. Curr Opin Cell Biol 1998; 10:248-53.
35. Sinet P, Couturier J, Dutrillaux B, Poissonnier M, Raoul O, Rethore M et al. Trisomy 21 and superoxide dismutase-1 (IPO-A). Tentative localization of sub-band 21Q22.1. Exp Cell Res 1976;97:47-55.
36. Gilles L, Ferradini C, Foos J, Pucheault J, Allard D, Sinet P et al. The estimation of red cell superoxide dismutase activity by pulse radiolysis in normal and trisomic 21 subjects. FEBS Lett 1976;69:55-8.
37. Sinet P, Lavelle F, Michelson A, Jerome H. Superoxide dismutase activities of blood platelet in trisomy 21. Biochem Biophys Res Common 1975;67:904-9.
38. Feaster W, Kwok L, Epstein C. Dosage effects for superoxide dismutase-1 in nucleated cells aneuploid for chromosome 21. Am J Hum Genet 1977;29:563-70.
39. Muchova J, Sustrova M, Garaiova I, Liptakova A, Blazicek P, Kvasnicka P et al. Influence of age on activities of antioxidant enzymes and lipid peroxidation products in erythrocytes and neutrophils of Down syndrome patients. Free Radic Biol Med 2001;31:499-508.
40. Pastor M, Sierra C, Dolade M, Navarro E, Brandi N, Cabre E et al. Antioxidant enzymes and fatty acid status in erythrocytes of Down's syndrome patients. Clin Chem 1998;44:924-9.
41. Percy M, Dalton A, Markovic V, McLachlan D, Hummel J, Rusk A et al. Red cell superoxide dismutase, glutathione peroxidase and catalase in Down syndrome patients with and without manifestations of Alzheimer disease. Am J Med Genet 1990;35:459-67.
42. Banerjee S, Smallwood A, Nargund G, Campbell S. Placental morphogenesis in pregnancies with Down's syndrome might provide a clue to pre-eclampsia. Placenta 2002;123:172-4.
43. Burton G, Hempstock J, Jauniaux E. Oxygen, early embryonic metabolism and free radical-mediated embryopathies. Reprod Biomed Online 2003;6:84-96.
44. Wang Y, Walsh S. Increased superoxide generation is associated with decreased superoxide dismutase activity and mRNA expression in placental trophoblast cells in pre-eclampsia. Placenta 2001;22:206-12.
45. Jauniaux E, Bao S, Eblen A, Li X, Lei ZM, Mewis S et al. HCG concentration and receptor gene expression in placental tissue from trisomy 18 and 21. Mol Hum Reprod 2000;6:5-10.
46. Newby D, Aitken DA, Crossley JA, Howatson AG, Macri JN, Connor JM. Biochemical markers of trisomy 21 and the pathophysiology of Down's syndrome pregnancies. Prenat Diagn 1997;17:941-51.